Senior Financial Analyst @ (January 2005 - January 2011)
Staff Accountant @ (January 2004 - January 2005)
Michael Gordon Education
Villanova University
Master of Business Administration - MBA (Marketing)
Penn State University
Bachelor of Science - BS (Finance with International Studies)
Michael Gordon Skills
Accounting
Accruals
Analytics
Biotechnology Industry
Budget Process
Budgeting
Budgets
Business Planning
Business Process Improvement
Capex
Capital Raising
Cash Management
Close Process
Corporate FP&A
Corporate Finance
Cost Accounting
Cross-functional Team Leadership
Dashboard
Data Analysis
Essbase
Executive Team
Finance
Financial Analysis
Financial Forecasting
Financial Modeling
Financial Operations
Financial Performance
Financial Planning
Financial Reporting
Financial Systems
Financial Variance Analysis
Forecasting
Gross to Net
Hyperion
Hyperion Enterprise
Hyperion Financial Reporting
Hyperion Reports
Investment Decisions
Managed Care
Management
Managerial Finance
Margin Analysis
Operational Efficiency
P & L Oversight
P&L Management
Pharmaceutical Industry
Planning Budgeting & Forecasting
Process Improvement
Product Launch
Program Management
Resource Allocation
SAP
SG&A
Sales
Sarbanes-Oxley Act
Segmentation
Strategic Analysis
Strategic Financial Management
Strategic Financial Planning
Strategic Leadership
Team Management
Therapeutic Areas
Trend Analysis
Variance Analysis
Variance Explanations
Michael Gordon Summary
Michael Gordon, based in Boston, MA, US, is currently a Senior Director, FP and A at Zevra Therapeutics. Michael Gordon brings experience from previous roles at Servier Pharmaceuticals, ImmunoGen, Inc., Self-employed and Shire. Michael Gordon holds a Master of Business Administration - MBA in Marketing @ Villanova University. With a robust skill set that includes Accounting, Accruals, Analytics, Biotechnology Industry, Budget Process and more. Michael Gordon has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Michael Gordon?
Find contact details for 700 million professionals.